Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.
The myeloproliferative neoplasms (MPNs) are a group of clonal disorders that arise from a pluripotent hematopoietic stem cell and are characterized by excess cellular proliferation. These disorders tend to be chronic in nature and can terminate over time into a bone marrow failure syndrome characterized by marrow fibrosis or transform into a leukemic phase. MPNs are predominantly diseases of the elderly and this is one reason why until very recently the standard treatment was supportive care. The only curative modality for these disorders is allogeneic hematopoietic cell transplantation. The introduction of reduced-intensity conditioning regimens now allows this life-saving therapy to be offered to elderly patients who were previously considered ineligible for high-dose conditioning owing to age or comorbidity. In this review, we will summarize the current strategies and future directions regarding the use of reduced-intensity conditioning regimens in the treatment of MPNs.
Ramakrishnan
Aravind
A
Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, 1100 Fairview Avenue N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA. aramakri@fhcrc.org
Sandmaier
Brenda M
BM
D019046:Bone Marrow Neoplasms / Q000473:pathology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D009196:Myeloproliferative Disorders / Q000473:pathology / Q000628:therapy*; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous
Bone Marrow Transplant. 2000 Feb;25(4):345-50
10723575
Bone Marrow Transplant. 2008 Dec;42(11):757-60
18762765
Br J Haematol. 2006 Nov;135(3):367-73
16972981
Nat Rev Immunol. 2008 Sep;8(9):726-36
19172693
Biol Blood Marrow Transplant. 2007 Jan;13(1 Suppl 1):64-72
17222772
Blood. 2007 Jan 15;109(2):500-2
16990603
Clin Adv Hematol Oncol. 2005 Oct;3(10):799-819
16258490
Blood. 2002 Mar 15;99(6):2255-8
11877308
Biol Blood Marrow Transplant. 2007 Jul;13(7):844-52
17580263
Blood. 1985 Sep;66(3):664-72
3896348
Lancet. 2005 Mar 19-25;365(9464):1054-61
15781101
Ann Intern Med. 1988 Jun;108(6):806-14
3285744
Blood. 1996 Aug 1;88(3):1013-8
8704209
Nature. 2005 Apr 28;434(7037):1144-8
15793561
Blood. 2009 Dec 24;114(27):5444-53
19786617
Cancer Res. 2009 Mar 15;69(6):2408-15
19244101
Blood. 2007 Nov 1;110(9):3456-62
17652620
Biol Blood Marrow Transplant. 2007 Mar;13(3):355-65
17317589
Br J Haematol. 2008 Dec;143(5):748-51
19036020
Blood. 2003 Mar 1;101(5):2043-8
12406916
Curr Opin Hematol. 2008 Mar;15(2):127-33
18300759
Blood. 1990 Nov 1;76(9):1867-71
2224134
Leukemia. 2008 Feb;22(2):258-64
17989720
Clin Adv Hematol Oncol. 2007 Jul;5(7):560-70
17679930
Br J Haematol. 2008 Apr;141(1):80-3
18324970
Blood. 2009 Jul 30;114(5):1099-109
19423725
Blood. 2007 Apr 1;109(7):2791-3
17119111
Blood. 2007 Apr 15;109(8):3207-13
17185463
Blood. 1999 Jul 15;94(2):825-31
10397751
Blood. 2002 Sep 15;100(6):2243-5
12200391
Blood. 2003 Jan 15;101(2):469-72
12393598
Best Pract Res Clin Haematol. 2008 Jun;21(2):165-76
18503984
Exp Hematol. 2007 Nov;35(11):1719-22
17976523
J Clin Oncol. 2005 Oct 20;23(30):7583-93
16234522
Blood. 2009 Mar 26;113(13):2895-901
18988864
Biol Blood Marrow Transplant. 2002;8(9):493-500
12374454
Hematology Am Soc Hematol Educ Program. 2001;:375-91
11722994
Pathologica. 2010 Jun;102(3):83-7
21171509
Leukemia. 2006 Oct;20(10):1661-72
16871277
Blood. 2007 Dec 15;110(13):4614-7
17881635
Blood. 2006 Nov 1;108(9):3216-22
16835378
J Clin Oncol. 2005 Mar 20;23(9):1993-2003
15774790
Hematol Oncol Clin North Am. 2004 Jun;18(3):685-702, x
15271400
J Clin Oncol. 2007 Sep 20;25(27):4246-54
17724349
Biol Blood Marrow Transplant. 2008 Feb;14(2):246-55
18215785
Blood. 2009 Aug 6;114(6):1226-35
19515724
Cytotherapy. 2008;10(1):13-20
18202970
N Engl J Med. 1979 May 10;300(19):1068-73
34792
Cancer Cell. 2005 Apr;7(4):387-97
15837627
Blood. 1999 May 1;93(9):2831-8
10216077
J Clin Oncol. 2008 Dec 10;26(35):5767-74
19001324
Nat Rev Cancer. 2007 Sep;7(9):673-83
17721432
Semin Oncol. 1995 Aug;22(4):405-11
7638637
Blood. 2001 Jun 1;97(11):3390-400
11369628
Haematologica. 2000 Mar;85(3):304-13
10702821
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3921-6
15001702
J Immunol. 2001 Aug 15;167(4):2087-96
11489992
Lancet. 2004 May 1;363(9419):1439-41
15121408
Biol Blood Marrow Transplant. 2007 Jan;13(1 Suppl 1):87-97
17222778
Leuk Lymphoma. 2007 Dec;48(12):2352-9
18067010
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8120-5
15148407
Blood. 2005 Oct 15;106(8):2912-9
15994282
Hematology Am Soc Hematol Educ Program. 2006;:240-5
17124067
J Immunol. 2006 Jul 15;177(2):944-9
16818749
Cancer. 2006 Feb 1;106(3):623-30
16369987
Hematol Oncol Clin North Am. 1999 Oct;13(5):1041-57, vii-viii
10553260
Blood. 1991 Apr 15;77(8):1660-5
2015394
Hematology Am Soc Hematol Educ Program. 2007;:47-54
18024608
Blood. 1998 May 15;91(10):3630-6
9572998
Expert Opin Drug Saf. 2009 May;8(3):305-15
19505263
Leukemia. 2003 Sep;17(9):1707-12
12970768
Blood. 2005 May 15;105(10):4115-9
15671439
Transplant Proc. 1981 Mar;13(1 Pt 1):248-51
7022833
Biol Blood Marrow Transplant. 2004 Oct;10(10):698-708
15389436
Blood. 2005 Jun 1;105(11):4532-9
15731182
Leukemia. 2007 Jul;21(7):1357-62
17508002
Best Pract Res Clin Haematol. 2006;19(4):637-53
16997174
Curr Opin Oncol. 2009 Jun;21 Suppl 1:S3-5
19561410
Blood. 1995 Sep 1;86(5):2041-50
7655033
Hematology Am Soc Hematol Educ Program. 2006;:381-9
17124087
Blood. 2003 Jan 15;101(2):441-5
12393604
Bone Marrow Transplant. 2005 Dec;36(12):1043-7
16247424
Blood. 1990 Dec 15;76(12):2462-5
2265242
Biol Blood Marrow Transplant. 2006 Nov;12(11):1161-8
17085309
Best Pract Res Clin Haematol. 2006;19(3):519-33
16781487
Blood. 2009 Oct 29;114(18):3956-9
19713456
Cancer. 2005 Nov 1;104(9):1931-8
16178004
Blood. 2003 Jul 15;102(2):470-6
12649133
Bone Marrow Transplant. 2006 Feb;37(4):339-44
16415898
Blood. 1997 Apr 15;89(8):3048-54
9108426
Blood. 1997 Apr 15;89(8):3055-60
9108427
Blood. 2009 Dec 17;114(26):5264-70
19812383
Biol Blood Marrow Transplant. 2009 Mar;15(3):367-9
19203728
N Engl J Med. 1981 Jun 18;304(25):1529-33
7015133
Leukemia. 2004 Sep;18(9):1468-75
15241437
Blood. 2007 Oct 1;110(7):2744-8
17595333
Blood. 2002 Sep 1;100(5):1590-5
12176876
Lancet. 1987 Jul 25;2(8552):175-8
2885638
Leukemia. 2005 Jun;19(6):990-7
15800667
Leukemia. 2007 Aug;21(8):1658-68
17541402
Blood. 2008 May 1;111(9):4813-6
18326813
Clin Adv Hematol Oncol. 2009 May;7(5):334-42
19521323
Bone Marrow Transplant. 2004 Dec;34(12):1083-8
15489879
Hematology Am Soc Hematol Educ Program. 2007;:384-91
18024655
Bone Marrow Transplant. 2006 Dec;38(11):721-7
17013423
Blood. 2002 Jun 15;99(12):4357-63
12036862
N Engl J Med. 2005 Apr 28;352(17):1779-90
15858187